Umea, Sweden

Andreas Larsson

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Washington University. Active years: 2008-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Larsson. Retrieved from https://idiyas.com/inventor/andreas-larsson-533v35zq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Andreas Larsson in Bacterial Inhibition

Introduction

Andreas Larsson is a notable inventor based in Umea, Sweden. He has made significant contributions to the field of pharmaceutical compositions aimed at inhibiting bacterial adherence. With a total of 2 patents, his work focuses on innovative solutions to combat bacterial infections.

Latest Patents

Larsson's latest patents include the development of novel amino methylated 2-pyridinones. These compounds serve as precursors, intermediates, and derivatives that are crucial in the preparation of pharmaceutical compositions. The methods described in his patents highlight their use in inhibiting pili formation in bacteria. Furthermore, these compounds are designed to inhibit biofilm formation, which is essential for preventing bacterial adherence to host cells.

Career Highlights

Andreas Larsson is affiliated with Washington University, where he continues to advance his research in the field of microbiology and pharmaceuticals. His innovative work has the potential to significantly impact the treatment of bacterial infections.

Collaborations

Larsson has collaborated with esteemed colleagues such as Scott J Hultgren and Jerome Pinkner. These partnerships enhance the research and development of his patented technologies.

Conclusion

Andreas Larsson's contributions to the field of bacterial inhibition through his innovative patents demonstrate his commitment to advancing medical science. His work holds promise for improving treatment options against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…